Smith & Nephew(SNN) - 2024 Q1 - Earnings Call Transcript

So in summary, a solid performance in Q1, despite the expected phasing headwinds. Much of the business is performing strongly, OUS recon, Pharma & Extremities, Sports Medicine Joint Repair and negative pressure wound therapy. As we move through Q2, our collective focus remains on addressing the remaining areas of weakness in US Knees and Hips and on driving further operational and financial improvements across the business. So thank you for listening. With that, I'll hand you back to the moderator for Q&A. ...